粪便微生物组的保留与移植物抗宿主病严重程度降低相关
该研究对266例异基因造血细胞移植(allo-HCT)受者的1303份粪便样本进行16S核糖体基因测序,按急性移植物抗宿主病(aGVHD)受累器官分类。结果显示,在发病前20天,GVHD患者梭菌纲丰度、丁酸盐产生菌计数及严格厌氧菌与兼性厌氧菌比值(S/F比值)均低于无GVHD受者;肠道GVHD患者发病前微生物多样性显著降低。梭菌纲和丁酸盐产生菌丰度及S/F比值可预测更长的总生存期,较高丁酸盐产生菌丰度和较高S/F比值与GVHD相关死亡风险降低相关。
要点
- 发病前20天,GVHD患者梭菌纲丰度、丁酸盐产生菌计数及S/F比值低于无GVHD受者。
- 肠道GVHD患者发病前微生物多样性显著降低,下消化道GVHD患者S/F比值低于孤立上消化道GVHD患者。
- 梭菌纲和丁酸盐产生菌丰度及S/F比值可预测更长总生存期,较高丁酸盐产生菌丰度和S/F比值与GVHD相关死亡风险降低相关。
核心结论
- 肠道微生物组可作为allo-HCT后GVHD患者结局的生物标志物。
研究设计与样本
- 研究纳入266例异基因造血细胞移植(allo-HCT)受者,对1303份粪便样本进行16S核糖体基因测序,并根据aGVHD受累器官对患者分类。
主要发现
- 在发病前20天,GVHD患者梭菌纲成员丰度、丁酸盐产生菌计数及严格厌氧菌与兼性厌氧菌比值(S/F比值)均低于无GVHD的移植物受者。
- 肠道GVHD患者发病前微生物多样性显著降低;下消化道aGVHD患者S/F厌氧菌比值低于孤立上消化道aGVHD患者。
- 在发病后20天,仅在伴有胃肠道受累的GVHD患者中观察到菌群失调,尤其是下消化道疾病患者。
- 梭菌纲和丁酸盐产生菌丰度及S/F厌氧菌比值可预测更长的总生存期;较高丁酸盐产生菌丰度和较高S/F厌氧菌比值与GVHD相关死亡风险降低相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Following allogeneic hematopoietic cell transplantation (allo-HCT), the gastrointestinal (GI) tract is frequently affected by acute graft-versus-host disease (aGVHD), the pathophysiology of which is associated with a dysbiotic microbiome. Since microbial composition varies along the length of the GI tract, the authors hypothesized that microbiome features correlate with the pattern of organ involvement after allo-HCT. We evaluated 266 allo-HCT recipients from whom 1303 stool samples were profiled by 16S ribosomal gene sequencing. Patients were classified according to which organs were affected by aGVHD. In the 20 days prior to disease onset, GVHD patients had lower abundances of members of the class Clostridia, lower counts of butyrate producers, and lower ratios of strict-to-facultative (S/F) anaerobic bacteria compared with allograft recipients who were free of GVHD. GI GVHD patients showed significant reduction in microbial diversity preonset. Patients with lower GI aGVHD had lower S/F anaerobe ratios compared with those with isolated upper GI aGVHD. In the 20 days after disease onset, dysbiosis was observed only in GVHD patients with GI involvement, particularly those with lower-tract disease. Importantly, Clostridial and butyrate-producer abundance as well as S/F anaerobe ratio were predictors of longer overall survival; higher abundance of butyrate producers and higher S/F anaerobe ratio were associated with decreased risk of GVHD-related death. These findings suggest that the intestinal microbiome can serve as a biomarker for outcomes of allo-HCT patients with GVHD.
引用
- Burgos da Silva M, Ponce DM, Dai A, et al. Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease. Blood. 2022. PMID: 35969834. doi:10.1182/blood.2021015352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。